- Home
- SPRB vs JAGX Comparison
SPRB vs JAGX Comparison
Compare SPRB & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRB
- JAGX
- Stock Information
- Founded
- SPRB 2014
- JAGX 2013
- Country
- SPRB United States
- JAGX United States
- Employees
- SPRB N/A
- JAGX N/A
- Industry
- SPRB Medicinal Chemicals and Botanical Products
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- SPRB Health Care
- JAGX Health Care
- Exchange
- SPRB Nasdaq
- JAGX Nasdaq
- Market Cap
- SPRB N/A
- JAGX 12.9M
- IPO Year
- SPRB 2020
- JAGX N/A
- Fundamental
- Price
- SPRB $0.33
- JAGX $0.25
- Analyst Decision
- SPRB Hold
- JAGX
- Analyst Count
- SPRB 7
- JAGX 0
- Target Price
- SPRB $2.17
- JAGX N/A
- AVG Volume (30 Days)
- SPRB 282.5K
- JAGX 574.3K
- Earning Date
- SPRB 05-12-2025
- JAGX 05-13-2025
- Dividend Yield
- SPRB N/A
- JAGX N/A
- EPS Growth
- SPRB N/A
- JAGX N/A
- EPS
- SPRB N/A
- JAGX N/A
- Revenue
- SPRB $7,101,000.00
- JAGX $10,480,000.00
- Revenue This Year
- SPRB N/A
- JAGX $18.18
- Revenue Next Year
- SPRB N/A
- JAGX $40.06
- P/E Ratio
- SPRB N/A
- JAGX N/A
- Revenue Growth
- SPRB N/A
- JAGX N/A
- 52 Week Low
- SPRB $0.32
- JAGX $0.23
- 52 Week High
- SPRB $0.87
- JAGX $21.60
- Technical
- Relative Strength Index (RSI)
- SPRB 30.94
- JAGX 20.72
- Support Level
- SPRB $0.32
- JAGX $0.23
- Resistance Level
- SPRB $0.34
- JAGX $0.50
- Average True Range (ATR)
- SPRB 0.02
- JAGX 0.05
- MACD
- SPRB -0.00
- JAGX -0.03
- Stochastic Oscillator
- SPRB 13.27
- JAGX 5.93
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.